Insider Trading Alert - Macquarie Infrastructure Company And 2 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 9, 2013, 43 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $923.98 to $21,245,474.64.

Highlighted Stocks Traded by Insiders:

Macquarie Infrastructure Company (MIC) - FREE Research Report

Macquarie Infrastructure Management (USA) INC who is Director at Macquarie Infrastructure Company sold 395,400 shares at $53.73 on Oct. 9, 2013. Following this transaction, the Director owned 3.0 million shares meaning that the stake was reduced by 11.76% with the 395,400 share transaction.

The shares most recently traded at $53.92, up $0.19, or 0.35% since the insider transaction.

The average volume for Macquarie Infrastructure Company has been 265,000 shares per day over the past 30 days. Macquarie Infrastructure Company has a market cap of $2.8 billion and is part of the services sector and wholesale industry. Shares are up 16.4% year to date as of the close of trading on Friday.

Macquarie Infrastructure Company LLC, through its subsidiaries, owns, operates, and invests in a diversified group of infrastructure businesses in the United States. The stock currently has a dividend yield of 6.6%. Currently there are 5 analysts that rate Macquarie Infrastructure Company a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MIC - FREE

TheStreet Quant Ratings rates Macquarie Infrastructure Company as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Macquarie Infrastructure Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Monsanto Company (MON) - FREE Research Report

Ringenberg Nicole M who is VP and Controller at Monsanto Company sold 3,500 shares at $105.02 on Oct. 9, 2013. Following this transaction, the VP and Controller owned 2,041 shares meaning that the stake was reduced by 63.17% with the 3,500 share transaction.

The shares most recently traded at $104.68, down $0.34, or 0.33% since the insider transaction. Historical insider transactions for Monsanto Company go as follows:

  • 4-Week # shares sold: 5,276
  • 12-Week # shares sold: 6,676
  • 24-Week # shares sold: 46,756

The average volume for Monsanto Company has been 2.8 million shares per day over the past 30 days. Monsanto Company has a market cap of $56.2 billion and is part of the basic materials sector and chemicals industry. Shares are up 11.37% year to date as of the close of trading on Friday.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The stock currently has a dividend yield of 1.63%. The company has a P/E ratio of 22.9. Currently there are 12 analysts that rate Monsanto Company a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MON - FREE

TheStreet Quant Ratings rates Monsanto Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Monsanto Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 19,000 shares at $9.53 on Oct. 9, 2013. Following this transaction, the CEO & Chairman owned 136.8 million shares meaning that the stake was reduced by 0.01% with the 19,000 share transaction.

The shares most recently traded at $9.95, up $0.42, or 4.22% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 24-Week # shares bought: 4,300

The average volume for Opko Health has been 2.7 million shares per day over the past 30 days. Opko Health has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are up 81.5% year to date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook's Investors Have a Big Day Ahead

Facebook's Investors Have a Big Day Ahead

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox